Literature DB >> 1330395

Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer.

K Kubota1, S Yamada, K Ishiwata, M Ito, T Ido.   

Abstract

Two cases of lung cancer were studied with positron emission tomography (PET) using L-[methyl-C-11]methionine (C-11 Met) and CT scans five to six times during long-term follow-up after radiotherapy. In a large cell carcinoma with mediastinal invasion, C-11 Met tumor uptake showed a rapid decrease after radiotherapy, corresponding to clinical improvement, and detected recurrence at 11 months, as confirmed by biopsy. Tumor volume by CT showed no significant changes during this time. A squamous cell carcinoma of the superior sulcus (Pancoast type) showed rapid changes in C-11 Met tumor uptake and similar changes in tumor volume during two courses of radiotherapy and recurrence over a period of 25 months. PET evaluation of tumor viability seems to be valuable for treatment evaluation, and results match the tumor volume changes measured by CT.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330395     DOI: 10.1097/00003072-199211000-00009

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  7 in total

1.  Requirements for clinical PET: comparisons within Europe.

Authors:  Michael Bedford; Michael N Maisey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

2.  Pattern of Imaging after Lung Cancer Resection. 1992-2005.

Authors:  Gulshan Sharma; Shawn P E Nishi; Yu-Li Lin; Yong-Fang Kuo; James S Goodwin; Taylor S Riall
Journal:  Ann Am Thorac Soc       Date:  2016-09

Review 3.  Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?

Authors:  C S Brock; S R Meikle; P Price
Journal:  Eur J Nucl Med       Date:  1997-06

Review 4.  Tracer imaging in lung cancer.

Authors:  H M Abdel-Dayem; A Scott; H Macapinlac; S Larson
Journal:  Eur J Nucl Med       Date:  1994-01

5.  Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine: a preliminary study.

Authors:  K Kubota; S Yamada; K Ishiwata; M Ito; T Fujiwara; H Fukuda; M Tada; T Ido
Journal:  Eur J Nucl Med       Date:  1993-06

6.  Assessment of tumour necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: comparison with CT scan.

Authors:  C Aktolun; H Bayhan; Y Pabuccu; H Bilgic; H Acar; R Koylu
Journal:  Eur J Nucl Med       Date:  1994-09

7.  A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy.

Authors:  Mark A Henderson; David J Hoopes; James W Fletcher; Pei-Fen Lin; Mark Tann; Constantin T Yiannoutsos; Mark D Williams; Achilles J Fakiris; Ronald C McGarry; Robert D Timmerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-25       Impact factor: 7.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.